Silicon Valley Capital Partners »

Crispr Therapeutics shares owned by Silicon Valley Capital Partners

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Silicon Valley Capital Partners from 13F filings

Historical chart of Silicon Valley Capital Partners investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Silicon Valley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Silicon Valley Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.5k 100 64.81

More positions owned by Silicon Valley Capital Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Information Technology Etf Etf (VGT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Amazon Stock (AMZN)
Meta Platforms Inc Cl A Stock (META)
Ishares S&p 500 Growth Etf Etf (IVW)
Broadcom Stock (AVGO)
Oracle Corp Stock (ORCL)
Servicenow Stock (NOW)

View all positions for Silicon Valley Capital Partners

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics